Security key
00791X100
AEON Biopharma, Inc. - Class A Common Stock (AEON)
CUSIP: 00791X100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Class A Common Stock
- Total 13F shares
- 9,572,064
- Total 13F value
- $10,050,752
- Share change
- +3,830,394
- SEC-reported price per share
- $1.05
- Number of holders
- 30
- Value change
- +$4,021,961
- Number of buys
- 18
- Number of sells
- 10
- Shares outstanding
- 39,736,842
Holder snapshot
6 signals
Security identity
Who this page is about.
1 source field
Report period
Q3 2024
Institutions
30
Top holders
10
AEON full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X100
Recent filing periods:
Ownership snapshot
Top reported holders of AEON - AEON Biopharma, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PALMISANO ROBERT J
Disclosed value leader
Atalaya Capital Managemen...
Comparable rows
15/15
Latest evidence
25 Jul 2024
13D/G
13F
Lead comparable stake: 5.7%
13D/G row: PALMISANO ROBERT J
Showing 1-6 of 15 holder rows.
Quick read
PALMISANO ROBERT J leads the comparable SEC ownership view at 5.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
PALMISANO ROBERT J
5.7%
Atalaya Capital Management LP
9.2%
Polar Asset Management Partners Inc.
9.2%
VANGUARD GROUP INC
1.9%
BlackRock Finance, Inc.
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PALMISANO ROBERT J |
13D/G
Robert J Palmisano
|
5.7%
|
$158,550
2,265,000 shares
|
$0 | 25 Jul 2024 |
| Atalaya Capital Management LP |
13F
Company
|
9.2%
|
$3,279,938
3,675,000 shares
|
— | 30 Jun 2024 |
| Polar Asset Management Partners Inc. |
13F
Company
|
9.2%
|
$3,273,323
3,675,000 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$788,910
751,343 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.69%
|
$285,932
272,317 shares
|
— | 30 Jun 2024 |
| Ikarian Capital, LLC |
13F
Company
|
0.65%
|
$270,876
257,977 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
9,572,064
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
25
Q3 2024 holders
30
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend